Cadrenal Therapeutics Inc (CVKD)
0.4926
+0.03
(+5.94%)
USD |
NASDAQ |
May 03, 16:00
0.4926
0.00 (0.00%)
After-Hours: 19:44
Cadrenal Therapeutics Cash and Short Term Investments (Quarterly): 8.402M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.402M |
| September 30, 2023 | 9.109M |
| June 30, 2023 | 3.230M |
| March 31, 2023 | 4.028M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0326M |
| September 30, 2022 | 0.1031M |
| June 30, 2022 | 0.0596M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0326M
Minimum
Dec 2022
9.109M
Maximum
Sep 2023
3.566M
Average
3.230M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Tenax Therapeutics Inc | 9.792M |
| Syra Health Corp | 3.280M |
| Relmada Therapeutics Inc | 96.32M |
| Minerva Neurosciences Inc | 40.91M |
| Adverum Biotechnologies Inc | 96.53M |